THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

POLARIS INSIGHTS

BioMarin anticipates $3. 8B-$3. 9B 2026 revenue while flagging $70M order deferrals

The development centers on bioMarin anticipates $3.8B-$3.9B 2026 revenue while flagging $70M order deferrals.

Read the full account of the story

More from the Markets desk

More from Markets · Back to Polaris Insights